Regeneron Pharmaceuticals (REGN) Consolidated Net Income (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded Consolidated Net Income of $1.95 billion in Q3 2026, up 33.5% from $1.46 billion a year earlier and up 50.3% from the prior quarter.
Regeneron Pharmaceuticals (REGN) Consolidated Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' Consolidated Net Income came in at $4.82 billion as of Sep 30, 2026, up 5.2% year-over-year; for FY2025, it was $4.5 billion, up 2.1% from FY2024.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- Across earlier years, Consolidated Net Income came in at $4.41 billion in FY2024 (+11.6%), $3.95 billion in FY2023 (-8.9%), $4.34 billion in FY2022 (-46.3%) and $8.08 billion in FY2021 (+129.9%).
- The Q3 2026 figure is the highest quarterly Consolidated Net Income since Q4 2021.
- On a year-over-year basis, Consolidated Net Income rose in three of the last eight quarters, with growth averaging 0.7%.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 94.0% in Q4 2021, against a decline of 72.5% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.3 billion (Q2 2026), $727.2 million (Q1 2026) and $844.6 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Regeneron Pharmaceuticals | 92.03 Bn | 57.37 Bn | 4.54 Bn | 1.95 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.95 Bn |
| Jun 30, 2026 | 1.30 Bn |
| Mar 31, 2026 | 727.20 Mn |
| Dec 31, 2025 | 844.60 Mn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 808.70 Mn |
| Dec 31, 2024 | 917.70 Mn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.43 Bn |
| Mar 31, 2024 | 722.00 Mn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.01 Bn |
| Jun 30, 2023 | 968.40 Mn |
| Mar 31, 2023 | 817.80 Mn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.32 Bn |
| Jun 30, 2022 | 852.10 Mn |
| Mar 31, 2022 | 973.50 Mn |
| Dec 31, 2021 | 2.23 Bn |
Regeneron Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=REGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();